Peptris, an AI drug discovery startup, raises $1 million in the pre-seed round, led by Speciale Invest

Peptris Technologies has raised $1M in pre-seed funding led by Speciale Invest. The investment will support Peptris in advancing its AI-driven solutions for drug discovery, focusing on undruggable targets in oncology, inflammation, and rare diseases. The company's state-of-the-art AI platform narrows down chemical libraries to identify potential drug candidates, reducing the time and cost of the traditional drug discovery process. Peptris aims to leverage AI for the rapid discovery of novel therapies for rare diseases. The funding from Speciale Invest will accelerate the company's AI-powered programs and expand its drug pipeline.

from Gadgets Now https://ift.tt/gbUawsl
via IFTTT